Journal
INTERNATIONAL IMMUNOLOGY
Volume 19, Issue 11, Pages 1261-1270Publisher
OXFORD UNIV PRESS
DOI: 10.1093/intimm/dxm097
Keywords
dendritic cells; immunomodulation; innate immunity; viral infections
Categories
Ask authors/readers for more resources
Reactivation of latent human cytomegalovirus following allogeneic transplantation is a major cause of morbidity and mortality and predisposes to severe complications. Thymosin alpha 1 (T alpha 1), a naturally occurring thymic peptide, is approved for treatment of some viral infections and as an immune adjuvant. T alpha 1 successfully primed dendritic cells (DCs) for anti-microbial T helper type 1 resistance through Toll-like receptor (TLR) 9 signaling. We sought to determine here whether T alpha 1 could play a role in murine cytomegalovirus infection (MCMV). To this purpose, susceptible, resistant and TLR-deficient mice were infected with MCMV, treated with T alpha 1 and assessed for protection in term of microbiological and immunological parameters. T alpha 1 protected susceptible and resistant mice from MCMV infection. The anti-viral effect of T alpha 1 occurred through the activation of plasmacytoid DCs via the TLR9/myeloid differentiation primary response gene 88-dependent viral recognition sensing, leading to the activation of IFN regulatory factor 7 and the promotion of the IFN-alpha/IFN-gamma-dependent effector pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available